AUPH - Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
Bristol Myers Squibb (NYSE: BMY) is reportedly interested in acquiring Aurina Pharmaceuticals (NASDAQ: AUPH) . In this Motley Fool Live video recorded on Oct. 27 , Fool contributors Keith Speights and Brian Orelli discuss whether this deal would be a smart move for the big drugmaker.
For further details see:
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?